معرفی
Dr. Daniel Erskine is a researcher affiliated with Newcastle University, focusing on neurodegenerative diseases and mitochondrial dysfunction. His work spans Parkinson's disease, dementia with Lewy bodies, and rare monogenic disorders, with a particular emphasis on alpha-synuclein pathology.
- Publications since 2015 address Lewy body formation, mitochondrial quality control, and neuroinflammatory mechanisms.
- Collaborates with professors in neurology and mitochondrial medicine, contributing to both clinical and experimental studies.
- Recent work explores genomic DNA damage, autophagy-NAD axis targeting, and cerebellar degeneration in mitochondrial diseases.
- Develops diagnostic tools like alpha-synuclein seed amplification assays and investigates neurochemical changes in disease states.
۰مقاله منتشرشده
